Gene · 5300
Papers3,752
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,752
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer. | Cancer Lett | 2026 | 41241303 | PubTator, text mining | PubMed |
| Plant heat shock protein Hsp90 enhances stress resistance through integrating protein quality control, chloroplast protection, hormone signal network, and immune defense. | J Exp Bot | 2026 | 41078076 | PubTator, text mining | PubMed |
| Targeting PIN1 in Pancreatic Tumor Microenvironment with Peptide Amphiphiles Unleashes Immune Checkpoint Therapy. | Adv Healthc Mater | 2026 | 40990518 | PubTator, text mining | PubMed |
| Self-assembling heterodimeric prodrug nanoparticles for dual-targeted cancer therapy via the disruption of redox homeostasis and Pin1 degradation. | Biomaterials | 2026 | 40803234 | PubTator, text mining | PubMed |
| Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responses. | J Adv Res | 2026 | 40783069 | PubTator, text mining | PubMed |
| Scaffold Hopping and Optimization of Thiazole Hybrids as Selective PIN1 Inhibitors: A Computational Study. | Med Chem | 2026 | 40265424 | PubTator, text mining | PubMed |
| Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer. | RSC Med Chem | 2025 | 41574233 | PubTator, text mining | PubMed |
| Pin1 as a Central Modulator of Wnt/β-Catenin Signaling in Pulmonary Fibrosis: Interplay with EBV-LMP1 and Therapeutic Implications. | Iran J Pharm Res | 2025 | 41477119 | PubTator, text mining | PubMed |
| ZMIZ2 interacts with PIN1 to promote lung adenocarcinoma EMT and metastasis via activation of the PI3K/AKT pathway. | Cell Biosci | 2025 | 41457239 | PubTator, text mining | PubMed |
| DAZAP1 promotes cancer progression and chemotherapy resistance by stabilizing PIN1 protein in gastric cancer. | Cell Biol Toxicol | 2025 | 41331184 | PubTator, text mining | PubMed |
| Context-aware gene dependency modeling via graph attention networks for precision oncology. | J Transl Med | 2025 | 41291726 | PubTator, text mining | PubMed |
| Circulating Pin1 Levels in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Case-Control Study. | Pulm Circ | 2025 | 41262940 | PubTator, text mining | PubMed |
| Prenatal PM2.5 exposure impairs hippocampal synaptic development in offspring via KDM5A-mediated epigenetic derepression of Pin1. | Ecotoxicol Environ Saf | 2025 | 41252976 | PubTator, text mining | PubMed |
| Targeting Pin1 to overcome immunosuppressive tumor microenvironment in MSS colorectal cancer. | Front Immunol | 2025 | 41246306 | PubTator, text mining | PubMed |
| BM-MSC-derived migrasomes reverse stroke-induced thymic atrophy and immunosuppression via Pin1 delivery to thymic epithelial cells. | J Neuroinflammation | 2025 | 41241718 | PubTator, text mining | PubMed |
| Mutual inhibition between EPFL2 and auxin extends the intervals of periodic leaf morphogenesis. | Nat Commun | 2025 | 41233331 | PubTator, text mining | PubMed |
| How evaluation choices distort the outcome of generative drug discovery. | J Cheminform | 2025 | 41225661 | PubTator, text mining | PubMed |
| Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer. | J Transl Med | 2025 | 41214647 | PubTator, text mining | PubMed |
| Conserved mode of nuclear lamina distortion by primate cytomegaloviruses: importance of the pSer22 motif, viral kinase and cis/trans isomerase Pin1 activity. | J Gen Virol | 2025 | 41171811 | PubTator, text mining | PubMed |
| The role of auxin transport through plasmodesmata in leaf vein canalization and patterning. | Front Plant Sci | 2025 | 41104425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5300/papers?page=3